Detrimental effects of pretransplant cisplatin-based chemotherapy on renal function after allogeneic hematopoietic cell transplantation for lymphoma
Bone Marrow Transplant
.
2020 Nov;55(11):2196-2198.
doi: 10.1038/s41409-020-0917-2.
Epub 2020 May 4.
Authors
Akio Onishi
1
,
Yoshihiro Inamoto
2
,
Kinuko Tajima
1
,
Junko Yamaguchi
1
,
Ichiro Kawashima
1
,
Akihisa Kawajiri
1
,
Tomonari Takemura
1
,
Ayumu Ito
1
,
Takashi Tanaka
1
,
Keiji Okinaka
1
,
Shigeo Fuji
1
,
Saiko Kurosawa
1
,
Sung-Won Kim
1
,
Takahiro Fukuda
1
Affiliations
1
Department of Hematopoietic Stem Cell Transplantation, National Cancer Center Hospital, Tokyo, Japan.
2
Department of Hematopoietic Stem Cell Transplantation, National Cancer Center Hospital, Tokyo, Japan. yinamoto@ncc.go.jp.
PMID:
32367076
DOI:
10.1038/s41409-020-0917-2
No abstract available
Publication types
Letter
Research Support, Non-U.S. Gov't
MeSH terms
Cisplatin
Hematopoietic Stem Cell Transplantation*
Humans
Lymphoma* / therapy
Transplantation, Homologous
Substances
Cisplatin
Grants and funding
18K08345/MEXT | Japan Society for the Promotion of Science (JSPS)